收藏切换
Clinical effect of Zhilong Xuetong capsules combined with butylphthalide soft capsules in treatment of convalescent cerebral infarction
收藏切换
Jianqiang ZHANG1, Yongping JIAO2, Ruile SHEN1, *
World Clinical Drug | 2025, 46(8) : 773 - 778
Less
收藏切换
World Clinical Drug | 2025, 46(8): 773-778
Clinical effect of Zhilong Xuetong capsules combined with butylphthalide soft capsules in treatment of convalescent cerebral infarction
Full
Jianqiang ZHANG1, Yongping JIAO2, Ruile SHEN1, *
Affiliations
  • 1.Department of Neurology, First Affiliated Hospital of Henan University of Science and Technology, Luoyang 471003, Henan Province, China
  • 2.Department of Neurology, Linying County People's Hospital, Luohe 462699, Henan Province, China
Published: 2025-08-10 doi: 10.13683/j.wph.2025.08.006
Outline
收藏切换
Objective

To observe the clinical efficacy of Zhilong Xuetong capsules combined with butylphthalide soft capsules in treatment of patients with convalescent cerebral infarction.

Methods

A total of 90 patients with convalescent cerebral infarction admitted to the First Affiliated Hospital of Henan University of Science and Technology from January 2020 to December 2023 were selected, and divided into control group and treatment group, with 45 cases in each group.The control group was given routine treatment, and the treatment group was given Zhilong Xuetong capsules combined with butylphthalide soft capsules. Both groups were treated for 2 weeks. The curative effects of the two groups and the National Institute of Health stroke scale(NIHSS) score, activity of daily living(ADL) score, anterior cerebral artery(ACA) blood flow velocity, basilar artery(BA) blood flow velocity, middle cerebral artery (MCA) blood flow velocity and serum neuron-specific enolase(NSE), heart-fatty acid binding protein(HFABP) and S100B protein levels and adverse reactions were compared between the two groups.

Results

The total effective rate of the treatment group was higher than that of the control group(91.11% vs. 71.11%, P<0.05). After treatment, NIHSS score in the treatment group was lower than that in the control group, ADL score was higher than that in the control group(P<0.05), ACA, MCA and BA blood flow velocity were higher than those in the control group(P<0.05), and seru m NSE, HFABP and S100hose in the control group were all lower than those in the control group(P<0.05). There was no significant difference in the rate of adverse reactions between the two group(P>0.05).

Conclusion

Zhilong Xuetong capsules combined with butylphthalide soft capsules has a significant effect on convalescent cerebral infarction, which can reduce the levels of serum NSE, HFABP and S100B protein, alleviate the damage of nerve function, and has high safety.

convalescent cerebral infarction  /  Zhilong Xuetong capsules  /  butylphthalide soft capsules  /  neuron-specific enolase  /  heart-type fatty acid binding protein  /  S100B protein
张建强, 焦永平, 沈瑞乐. 蛭龙血通胶囊联合丁苯酞软胶囊治疗脑梗死恢复期的临床效果. 世界临床药物, 2025 , 46 (8) : 773 -778 . DOI: 10.13683/j.wph.2025.08.006
Jianqiang ZHANG, Yongping JIAO, Ruile SHEN. Clinical effect of Zhilong Xuetong capsules combined with butylphthalide soft capsules in treatment of convalescent cerebral infarction[J]. World Clinical Drug, 2025 , 46 (8) : 773 -778 . DOI: 10.13683/j.wph.2025.08.006
Year 2025 volume 46 Issue 8
45
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.08.006
  • Receive Date:2025-04-15
  • Online Date:2026-11-09
  • Published:2025-08-10
Article Data
Affiliations
History
  • Received:2025-04-15
Funding
Affiliations
    1.Department of Neurology, First Affiliated Hospital of Henan University of Science and Technology, Luoyang 471003, Henan Province, China
    2.Department of Neurology, Linying County People's Hospital, Luohe 462699, Henan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.08.006
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT